Imunon, Inc.
IMNN
$1.98
-$0.04-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | 1.23M | 2.17M | -- |
| Gross Profit | -- | -- | -1.23M | -2.17M | -- |
| SG&A Expenses | 1.77M | 1.58M | 1.54M | 1.98M | 1.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.26M | 3.48M | 2.77M | 4.15M | 4.15M |
| Operating Income | -4.26M | -3.48M | -2.77M | -4.15M | -4.15M |
| Income Before Tax | -4.22M | -3.43M | -2.74M | -4.10M | -4.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.22M | -3.43M | -2.74M | -4.10M | -4.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.22M | -3.43M | -2.74M | -4.10M | -4.06M |
| EBIT | -4.26M | -3.48M | -2.77M | -4.15M | -4.15M |
| EBITDA | -4.19M | -3.40M | -2.69M | -4.08M | -4.11M |
| EPS Basic | -1.44 | -1.16 | -1.87 | -3.68 | -3.11 |
| Normalized Basic EPS | -0.90 | -0.73 | -1.17 | -2.30 | -1.95 |
| EPS Diluted | -1.44 | -1.16 | -1.87 | -3.68 | -3.11 |
| Normalized Diluted EPS | -0.90 | -0.73 | -1.17 | -2.30 | -1.95 |
| Average Basic Shares Outstanding | 2.93M | 2.94M | 1.47M | 1.12M | 1.30M |
| Average Diluted Shares Outstanding | 2.93M | 2.94M | 1.47M | 1.12M | 1.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |